Several large Medicare Advantage carriers accelerated fall outreach this week, pairing flu and COVID-19 reminders with renewed pitches for respiratory syncytial virus immunization after federal data showed adult RSV uptake stalled below planners’ targets last winter.
What the uptake numbers show
The Centers for Disease Control and Prevention recommends a single dose of RSV vaccine for adults 75 and older, and for adults 60–74 with certain risk factors. Pharmacy dashboards compiled by analysts at KFF suggest only a minority of eligible Medicare beneficiaries received an RSV dose in the 2025–26 season, even as hospitalization rates for older adults remained a focus for state health departments.
That gap matters for Medicare Advantage plans, which take capitated payments and face quality metrics tied to preventive care. Plans that miss vaccination benchmarks can see star-rating pressure and member churn when brokers compare offerings each fall.
How plans are changing the mailers
Humana, UnitedHealthcare, and CVS Aetna templates reviewed by InfoHandle now list RSV alongside flu and updated COVID-19 formulations in the same envelope sequence, rather than burying RSV on a secondary insert. Some letters add pharmacy walk-in hours and ride-share voucher language for members who reported transportation barriers in prior surveys.
Independent brokers said the bundled approach reduces “vaccine fatigue” confusion: seniors often asked whether RSV was annual like flu, when CDC guidance treats the first adult dose as long-lasting for many patients.
Pharmacy benefit managers also adjusted prior-authorization lists so retail pharmacists could bill MA plans for all three respiratory products in one visit, reducing abandoned second shots when copays stacked unexpectedly.
Clinical limits readers should keep in mind
RSV vaccines are not interchangeable with flu shots, and not every adult needs both on the same day. Clinicians may space injections to monitor reactions, especially in patients on anticoagulants. Immunocompromised adults should consult physicians because trial populations often under-represent the frailest nursing-home residents.
Absolute risk matters: RSV can hospitalize older adults, but baseline risk varies by age, lung disease, and congregate living. A relative risk headline without denominators can overstate benefit for healthy 60-year-olds while underserving the 80-plus group plans are trying to reach.
What happens next
The Centers for Medicare and Medicaid Services will publish updated star-measure drafts this fall, and plans are lobbying for clearer credit when members vaccinate at retail pharmacies outside plan-owned clinics. Meanwhile, community health centers in Sun Belt states said they are reserving weekend slots after MA call centers referred members who could not book through proprietary apps.
For beneficiaries, the practical step is to bring current medication lists to any walk-in visit and ask explicitly which respiratory vaccines are due this season—not assuming a flu shot covers RSV or COVID-19 boosters.
State insurance departments said they expect more consumer complaints if plans advertise “free vaccines” but steer members only to owned clinics with limited weekend hours—a tension outreach teams are trying to defuse before open enrollment mailers land in October.
